Measles: still a global threat despite vaccination

Measles is an airborne disease that can lead to serious complications or even death. It is found worldwide. The virus that causes it is highly contagious and spreads easily through breathing, coughing or sneezing.1 Measles is most common in children, but it can affect any susceptible individual. Before a vaccine became available, almost everyone contracted the disease during childhood2

Since the 1960s, protection against measles through vaccination is possible.2 But although a safe and cost-effective vaccination is available , people still die from the infection. In 2023 an estimated 107500 deaths from measles were registered by the WHO, most of them children.1 Also due to the COVID19 pandemic, the proportion of children receiving proper vaccination was decreasing from 2019 to 2023.1 Just recently, the WHO reported that the European region recorded 127,350 measles cases for 2024 – twice as many as for 2023 and the highest number since 1997.3

1 WHO: Measles - as of January 2025 (last update: November 2024)

2 ECDC: Factsheet about measles - as of January 2025 (last update: November 2023)

3 WHO: Highest number of measles cases in more than 25 years – as of March 2025 (last update: March 2025)


Infection diagnostics with EUROIMMUN

The detection of anti-measles virus IgM and IgG antibodies is most relevant to aid in the diagnosis of measles virus infection, for determination of the immune status of paediatric or adult patients and for epidemiological surveillance.

EUROIMMUN offers ELISAs and ChLIAs for the detection of IgM as well as IgG antibodies against measles virus. As of March 2025, the Anti-Measles Virus ELISA 2.0 (IgG) will also allow the analysis of dried blood spots (DBS) in addition to serum and plasma. Due to the minimally invasive sampling method and the high stability of the DBS on paper card, DBS diagnostics is of great benefit in routine diagnostics, in clinical studies or in regions with poor medical infrastructure.

Other relevant parameters:

Bordetella        

Thinking globally – acting locally
With over 35 years of experience in the field of laboratory diagnostics, we develop and globally distribute complete diagnostic solutions that are tailored to your local needs. Working together with local health and scientific authorities we stay aware of novel and/or urgent infection events and deliver appropriate solutions for infectious diseases diagnostics all over the world. With our unrivalled in-house development and production of diagnostic test systems as well as our automation and software solutions, we are able to respond rapidly to both small and large infection outbreaks, providing support and national and international health entities when and where it is needed.
Thinking globally – acting locally


To differentiate between whooping cough and other coughing illnesses

ELISA

  • Anti-Measles Virus ELISA 2.0 (IgG)
    → Data sheet (PDF)
  • Anti-Measles Virus ELISA (IgM)
    → Data sheet (PDF)
  • Anti-Measles Virus NP ELISA (IgM)
    → Data sheet (PDF)
  • CSF: Anti-Measles Virus ELISA (IgG)
    Order no. EI 2610-9601 G / M, EI 2610-9601-4 M, EI 2610-9601-L G

ChLIA

  • IDS Measles IgG
  • IDS Measles IgM
    Order no. IS-ID5901, IS-ID6001

Find out more about our test portfolio

Infections

 
 

EUROIMMUN's solutions for infection diagnostics

in Europe

 
 

More information